Prostate Cancer - Results from #26200

Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer - Abstract March 22, 2012

Prostate cancer risk prediction in a urology clinic in Mexico - Abstract March 22, 2012

Do additional cores from MRI cancer-suspicious lesions to systematic 12-core transrectal prostate biopsy give better cancer detection? - Abstract March 21, 2012

Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy - Abstract March 21, 2012

Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance - Abstract March 21, 2012

Urinary morbidity after permanent prostate brachytherapy - Impact of dose to the urethra vs. sources placed in close vicinity to the urethra - Abstract March 21, 2012

The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: Implications for treatment selection - Abstract March 21, 2012

Predicting rectal and bladder overdose during the course of prostate radiotherapy using dose-volume data from initial treatment fractions - Abstract March 21, 2012

Long-term outcomes after high-dose postprostatectomy salvage radiation treatment - Abstract March 21, 2012

Is primary prostate cancer treatment influenced by likelihood of extraprostatic disease? A Surveillance, Epidemiology and End Results patterns of care study - Abstract March 21, 2012

Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy - Abstract March 20, 2012

Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: A 12-year follow-up study - Abstract March 20, 2012

Androgenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: A systematic review - Abstract March 20, 2012

Flexible sigmoidoscopy in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: Added yield from a second screening examination - Abstract March 20, 2012

Focal therapy of prostate cancer: Evidence-based analysis for modern selection criteria - Abstract March 20, 2012

Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer - Abstract March 20, 2012

A panel of five circulating microRNAs as potential biomarkers for prostate cancer - Abstract March 20, 2012

What men say about surviving prostate cancer: Complexities represented in a decade of comments - Abstract March 20, 2012

Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer - Abstract March 20, 2012

Communicating health decisions: An analysis of messages posted to online prostate cancer forums - Abstract March 19, 2012

Page 1311 of 1437